William Hu
Signal active
Managing Partner
Bio
William Hu is a managing partner of Qiming Venture Partners. William co-leads Qiming’s practice in healthcare sector and has been closely involved with more than 20 new ventures, some of which have become public or billion dollar market cap companies. On behalf of Qiming, he invested in Tigermed, Tellgen, AmoyDx, Rendu Bio, ET Healthcare, Vinno Medical, APT Medical, Sanyou Orthopedic, Canbridge, Ark Bio, Arrail Dental, JHT Clinics, WeDoctor, Medsci Clinical, and etc.
Formerly, William served as a strategy consultant at IBM BCS, and Marketing & Sales management at several pharmaceutical companies.
William holds Bachelor of Medicine from Shanghai Medical University and MBA from ENPC SH Campus.
Location
Shanghai, Shanghai, China, Asia
Social
Primary Organization
Qiming Venture Partners
Founded
2006
Investment
946
Lead investment
517
Exits
78
Employees
51-100
Industry
Financial Services, Venture Capital, Finance
Jobs history
13
Allorion Therapeutics
Board member
Invalid date - Current
Yuanxin Huibao
Board member
Invalid date - Current
Yike Polymers
Board member
Invalid date - Current
Board member
Invalid date - Current
Newsoara
Board member
Invalid date - Current
Access Medical Systems
Board member
Invalid date - Current
Cornerstone Robotics
Board member
2021 - Current
Health Gene Technologies
Board member
2020 - Current
Oricell Therapeutics
Board member
2022 - Current
Bio Basic
Board Member
2010 - Current
Board Member
2017 - Current
Junhetang
Board Member
2013 - Current
Abbisko Therapeutics
Board Member
2019 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
William Hu is the Managing Partner at Qiming Venture Partners, based in Asia. With a background in Financial Services, William Hu has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
152
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Jun 22, 2024 | - | Series B - Alpha Biopharma | Qiming Venture Partners | 23.9M |
| Jul 01, 2024 | - | Series C - LaNova Medicines | Qiming Venture Partners | 43.8M |
| Jul 30, 2024 | LTZ Therapeutics | Series A - LTZ Therapeutics | Qiming Venture Partners | 20.0M |
| Aug 06, 2024 | Dr.Clear Aligner | Series A - Dr.Clear Aligner | Qiming Venture Partners | 14.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.